In This Article:
Physician services provider Pediatrix Medical Group, Inc. MD is set to report its first-quarter 2025 results on May 6, 2025, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings and revenues is pegged at 25 cents per share and $454.5 million, respectively. (See the Zacks Earnings Calendar to stay ahead of market-making news.)
The earnings estimate for the to-be-reported quarter has remained stable over the past 60 days. The bottom-line projection indicates a year-over-year increase of 25%. However, the Zacks Consensus Estimate for quarterly revenues suggests a year-over-year decrease of 8.2%.
Image Source: Zacks Investment Research
For 2025, the Zacks Consensus Estimate for Pediatrix Medical’s revenues is pegged at $1.9 billion, implying a decline of 6.6% year over year. Yet, the consensus mark for current year EPS is pegged at $1.55, implying growth of 2.7% on a year-over-year basis.
Pediatrix Medical beat the consensus estimate for earnings in each of the trailing four quarters, with the average surprise being 19.4%, as you can see below.
Pediatrix Medical Group, Inc. Price and EPS Surprise
Pediatrix Medical Group, Inc. price-eps-surprise | Pediatrix Medical Group, Inc. Quote
Pediatrix Medical’s Q1 Earnings Whispers
However, our proven model does not conclusively predict an earnings beat for MD this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the chances of an earnings beat. That is not the case here, as you will see below.
MDhas an Earnings ESP of 0.00% and a Zacks Rank #2. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
You can see the complete list of today’s Zacks #1 Rank stocks here.
Let’s see how things have shaped up before the first-quarter earnings announcement.
Q1 Factors to Note for Pediatrix Medical
Both the Zacks Consensus Estimate and our model estimate for first-quarter net patient service revenue indicate a 7.6% year-over-year decline. Moreover, both the consensus mark and our model estimate for hospital contract administrative fees predict a 10.7% decline from a year ago. These are likely to have affected the company’s top line in the first quarter.
The Zacks Consensus Estimate for same-facility revenue growth is pegged at 0.75% for the first quarter, as the same-facility patient volume growth is pegged at 0% and same-facility net reimbursement growth is pegged at 0.75%. The consensus mark for same-facility NICU patient days growth is pegged at 1.9%.